Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2013 | 3 |
2014 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.
PLoS One. 2013 May 21;8(5):e64186. doi: 10.1371/journal.pone.0064186. Print 2013.
PLoS One. 2013.
PMID: 23704979
Free PMC article.
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Stenholm L, Stoehlmacher-Williams J, Al-Batran SE, Heussen N, Akin S, Pauligk C, Lehmann S, Senff T, Hofheinz RD, Ehninger G, Kramer M, Goekkurt E.
Stenholm L, et al. Among authors: stoehlmacher williams j.
Ann Oncol. 2013 Oct;24(10):2581-2588. doi: 10.1093/annonc/mdt330. Epub 2013 Aug 23.
Ann Oncol. 2013.
PMID: 23975664
Free article.
Item in Clipboard
Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J, Obermann L, Ehninger G, Goekkurt E.
Stoehlmacher-Williams J, et al.
Anticancer Res. 2012 Feb;32(2):421-5.
Anticancer Res. 2012.
PMID: 22287728
Item in Clipboard
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).
Folprecht G, Gruenberger T, Bechstein W, Raab HR, Weitz J, Lordick F, Hartmann JT, Stoehlmacher-Williams J, Lang H, Trarbach T, Liersch T, Ockert D, Jaeger D, Steger U, Suedhoff T, Rentsch A, Köhne CH.
Folprecht G, et al. Among authors: stoehlmacher williams j.
Ann Oncol. 2014 May;25(5):1018-25. doi: 10.1093/annonc/mdu088. Epub 2014 Feb 27.
Ann Oncol. 2014.
PMID: 24585720
Free article.
Clinical Trial.
Item in Clipboard
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).
Al-Batran SE, Pauligk C, Homann N, Hartmann JT, Moehler M, Probst S, Rethwisch V, Stoehlmacher-Williams J, Prasnikar N, Hollerbach S, Bokemeyer C, Mahlberg R, Hofheinz RD, Luley K, Kullmann F, Jäger E.
Al-Batran SE, et al. Among authors: stoehlmacher williams j.
Eur J Cancer. 2013 Mar;49(4):835-42. doi: 10.1016/j.ejca.2012.09.025. Epub 2012 Oct 11.
Eur J Cancer. 2013.
PMID: 23063354
Clinical Trial.
Item in Clipboard
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
Folprecht G, Hamann S, Schütte K, Trarbach T, Stoehlmacher-Williams J, Ehninger G.
Folprecht G, et al. Among authors: stoehlmacher williams j.
BMC Cancer. 2014 Jul 19;14:521. doi: 10.1186/1471-2407-14-521.
BMC Cancer. 2014.
PMID: 25038824
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite